Teclistamab for BCMA-positive relapsed/refractory B acute lymphoblastic leukemia

Chezi Ganzel1, Ariella Tvito2, Mohammad Abu Eid2

  • 1The Hematology and Bone Marrow Transplantation Department, The Eisenberg Research and Development Authority, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem. ganzelc@szmc.org.il.

Haematologica
|September 10, 2026
PubMed

Related Concept Videos